Targeted doxorubicin-containing luteinizing hormone-releasing hormone analogue AN-152 inhibits the growth of doxorubicin-resistant MX-1 human breast cancers

Authors
Publication date
1 January 2003
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Sustaining member

    University of Miami: Scholarship Miami

    redirect
    oaioai:alma.01UOML_INST:114083770...
    Last time updated on 16/01/2024